Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
March 26, 2019
Patent Application Number
15222603
Date Filed
July 28, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
C1q is shown to be expressed in neurons, where it acts as a signal for synapse elimination. Methods are provided for protecting or treating an individual suffering from adverse effects of synapse loss. These findings have broad implications for a variety of clinical conditions, including treating and preventing neurodegenerative diseases such as Alzheimer's disease.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
